Download
1 / 19
190 likes | 365 Views
Corporate Presentation. INDOCO REMEDIES LTD. Indian Company with an International presence Turnover 09-10; Rs. 402.36 Crores Among the fastest growing Indian Companies Ranked 22nd in ORG IMS Rx Audit on MAT basis (ORG July 2010) Complete solution provider CRAMS – R&D, Regulatory & Mfg
E N D
Corporate Presentation INDOCO REMEDIES LTD
Indian Company with an International presence Turnover 09-10; Rs. 402.36 Crores Among the fastest growing Indian Companies Ranked 22nd in ORG IMS Rx Audit on MAT basis (ORG July 2010) Complete solution provider CRAMS – R&D, Regulatory & Mfg USFDA & MCC SA approved sterile eye drops facility UK MHRA, German Darmstad, ANVISA Brazil, MCC SA approved tablets, creams & capsules facility R&D and Regulatory capabilities Employs 3000 people 100 R&D scientists 1700 field staff About Us
Our Infrastructure • Corporate Office • Manufacturing Facilities • 5 Formulations facilities • 2 API facilities • R&D Centre • Depots & Branches • 34 Branches • Domestic Marketing Network • 7 divisions • PAN INDIA presence
Our Business • Indian Business • Branded Generic Formulations • APIs • International Business • Regulated Markets • Generics • CRAMS • APIs • Emerging Markets • Branded Generic Formulations • APIs
Indian Business • INDOCO – GP, CP, Gynaec, Life Style • SPADE – GP, CP, Paediatrician • WARREN –Dental, ENT • EXCEL – Opthal, ENT • SPERA – GP, Gynaec, Paediatrician • XTEND – GPs in Extra Urban Towns • ETERNA – CPs, Orthos, Gastro
API Infrastructure • KILO PLANT • Reaction Systems: 16 to 500 L • Total Reactor Volume: 1 cubic meters • Temperatures range: -55 to + 150 celsius • MULTI-TON PLANT • Reactor Capacity: 500 to 4000 L • Total Reactor Volume: 55 cubic meters • NEW OPHTHALMIC FACILITY • Reactor Capacity: 500 to 2000 L • Total reactor Volume: 15 cubic meters • INTERMEDIATES FACILITY • Reactor Capacity: 500 to 4000 L • Total Reactor Volume: 50 cubic meters
R & D • The state-of-art, stand alone, US $ 8 million R & D center for Formulations, API & Intermediates is located at Rabale- near New Mumbai • The R & D center in a area of 70,000 Sq.feet is designed to accommodate more than 200 scientists and technical personnel • This center is equipped with all required sophisticated hardware and software • The state of art cGMP standard KILO LAB is a part of this Research Center
F & D • Over 50 Scientists working estimated to go up to 75 next year. • Launched 12 new products during last year • Completed 20 and currently working on 19 euro dossiers and completed 5 and working on 18 ANDA projects. These are Indoco’s own IP. • Filed 4 ANDAs for various US partners • 926 Formulation Dossiers of 161 products submitted to 54 countries & 20 products are under preparation for 13 countries. • Executing contracts for Development work for International Companies. Multiple site transfer projects and Euro Dossiers completed to the satisfaction of the European Customers.
Regulatory • 8 USDMF • 1 DMF for Canada • 4 EU DMF / COS under preparation • 5 COS • 13 APIs open part of DMF submitted to Emerging Markets
Regulatory • Submitted 20 dossiers to various customers in Europe, New Zealand, Australia & SA • 19 in Pipeline • 5 ANDAs submitted • 3 ANDAs under preparation • 14 ANDAs in pipeline
Performance Highlights • Integrated player • R&D, Manufacturing & Marketing in both API & Formulations • Strong presence in India • Ranked 22nd in Rx Audit (IMS ORG) • Ranked 31st in Retail Audit (IMS ORG) • Focussed on exports • International Sales estimated to grow more than 40% • Partnering
Growth Drivers • Present domestic marketing set up • Focus on high value products such as anti infective, GI products, etc. • Intensive Pan – India coverage of medical fraternity through various marketing divisions. • Partnering with Watson and Aspen • Strong R&D Set up • New Plants at Goa and Waluj
